BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2463741)

  • 1. Ki-67 immunoperoxidase stain as marker for the histological grading of nervous system tumours.
    Shibata T; Burger PC; Kleihues P
    Acta Neurochir Suppl (Wien); 1988; 43():103-6. PubMed ID: 2463741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.
    Burger PC; Shibata T; Kleihues P
    Am J Surg Pathol; 1986 Sep; 10(9):611-7. PubMed ID: 2428262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
    Deckert M; Reifenberger G; Wechsler W
    J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours.
    Ostertag CB; Volk B; Shibata T; Burger P; Kleihues P
    Acta Neurochir (Wien); 1987; 89(3-4):117-21. PubMed ID: 3324650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study.
    Raghavan R; Steart PV; Weller RO
    Neuropathol Appl Neurobiol; 1990 Apr; 16(2):123-33. PubMed ID: 2161084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
    Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
    Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
    Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
    J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of the monoclonal antibody Ki-67 in determination of the growth fraction in pediatric brain tumors.
    Shibata T; Burger PC
    Childs Nerv Syst; 1987; 3(6):364-7. PubMed ID: 2453270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material.
    Karamitopoulou E; Perentes E; Diamantis I; Maraziotis T
    Acta Neuropathol; 1994; 87(1):47-54. PubMed ID: 7511316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.
    Zuber P; Hamou MF; de Tribolet N
    Neurosurgery; 1988 Feb; 22(2):364-8. PubMed ID: 2832782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve growth factor receptor in tumours of the human nervous system. Immunohistochemical analysis of receptor expression and tumour growth fraction.
    Prior R; Reifenberger G; Wechsler W
    Pathol Res Pract; 1989 Sep; 185(3):332-8. PubMed ID: 2478988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [KI-67 PAP stain for histologic grading of brain tumors by squash preparations].
    Shibata T; Ostertag CB; Volk B
    No To Shinkei; 1989 Jan; 41(1):55-60. PubMed ID: 2470401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction.
    Prior R; Reifenberger G; Wechsler W
    Virchows Arch A Pathol Anat Histopathol; 1990; 416(6):491-6. PubMed ID: 2110696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumours.
    Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
    Acta Neurochir (Wien); 1991; 109(1-2):37-41. PubMed ID: 1648862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cellular kinetics of cerebral glioma: study of the proliferative activity using monoclonal antibody Ki 67. Apropos of 60 cases].
    Parent M; Blond S; Gosset P; Lejeune JP; Lesoin F; Dhellemmes P; Jomin M; Christiaens JL; Dupont A
    Arch Anat Cytol Pathol; 1990; 38(3):81-5. PubMed ID: 2363592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ki-67 PAP stain as a supplement information of histological malignancy].
    Shibata T
    Rinsho Byori; 1988 Feb; 36(2):221-4. PubMed ID: 2454337
    [No Abstract]   [Full Text] [Related]  

  • 17. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
    Kordek R; Biernat W; Alwasiak J; Liberski PP
    Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis.
    Cummings TJ; Provenzale JM; Hunter SB; Friedman AH; Klintworth GK; Bigner SH; McLendon RE
    Acta Neuropathol; 2000 May; 99(5):563-70. PubMed ID: 10805102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas.
    Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
    Surg Neurol; 1990 May; 33(5):320-4. PubMed ID: 1691866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
    Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
    Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.